Infection phase is a predictor of pruritus in patients with hepatitis B virus infection.
dermatology
hepatitis B
itching
propensity score
pruritus
Journal
Biomedical reports
ISSN: 2049-9434
Titre abrégé: Biomed Rep
Pays: England
ID NLM: 101613227
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
28
02
2019
accepted:
10
06
2019
entrez:
25
7
2019
pubmed:
25
7
2019
medline:
25
7
2019
Statut:
ppublish
Résumé
Pruritus is a common pathogenesis in liver diseases, including chronic hepatitis B (CHB). The phases of hepatitis B virus (HBV) infection are defined in the American Association for the Study of Liver Diseases guidelines. However, it still remains unclear whether the phase independently affects pruritus. The aim of this study was to clarify the effect of HBV infection phase on pruritus in patients with HBV. Of the 1,631 patients that attended the joint research facilities and were interviewed regarding their pruritus between January and June 2016, 196 patients with HBV infection were selected for the present analysis. One-to-one propensity score-matching using 13 variables was performed between participants in the hepatitis B e antigen (HBe-Ag)-positive/negative immune-active phase group and the inactive CHB phase group. Data from 47 patients per group were included in the final analysis. The prevalence of pruritus in the inactive CHB phase was significantly lower than in the HBe-Ag-positive/negative immune-active phase (23 vs. 47%; P=0.031). Being in the inactive CHB phase was determined to be an independent risk factor for pruritus (odds ratio, 0.35; 95% confidence interval, 0.143-0.842; P=0.019). The progression to inactive CHB phase may contribute to the amelioration of pruritus in patients with HBV infection.
Identifiants
pubmed: 31338192
doi: 10.3892/br.2019.1224
pii: BR-0-0-1224
pmc: PMC6610217
doi:
Types de publication
Journal Article
Langues
eng
Pagination
63-69Références
Arthritis Rheum. 1999 Oct;42(10):2204-12
pubmed: 10524695
Dig Liver Dis. 2000 Oct;32(7):621-5
pubmed: 11142563
Hepatology. 2003 Aug;38(2):518-26
pubmed: 12883497
Ultrasound Med Biol. 2003 Dec;29(12):1705-13
pubmed: 14698338
Clin Gastroenterol Hepatol. 2003 Jul;1(4):297-302
pubmed: 15017671
J Eur Acad Dermatol Venereol. 2004 Sep;18(5):603-6
pubmed: 15324406
Hepatology. 2006 Jun;43(6):1317-25
pubmed: 16729309
Hepatology. 2007 Apr;45(4):1056-75
pubmed: 17393513
Neth J Med. 2007 Jul-Aug;65(7):227-34
pubmed: 17656809
Adv Ther. 2007 Sep-Oct;24(5):963-71
pubmed: 18029321
Annu Rev Pathol. 2006;1:23-61
pubmed: 18039107
Clin Rheumatol. 2009 Oct;28(10):1241-3
pubmed: 19653058
Clin Gastroenterol Hepatol. 2012 Jul;10(7):769-775.e2
pubmed: 22343690
Hepatology. 2012 Jun;55(6):2005-23
pubmed: 22488764
World J Gastroenterol. 2014 Nov 14;20(42):15860-6
pubmed: 25400473
Dig Dis Sci. 2016 Jun;61(6):1692-9
pubmed: 26743764
J Foot Ankle Surg. 2017 Mar - Apr;56(2):417-420
pubmed: 28231973
Hepatol Res. 2018 Jan;48(1):45-50
pubmed: 28322485
Hepatol Res. 2018 Feb;48(3):E252-E262
pubmed: 28877392
Am J Gastroenterol. 2018 Jan;113(1):49-55
pubmed: 29016567
Arch Dis Child. 1973 Oct;48(10):794-9
pubmed: 4749683
Proc R Soc Med. 1969 Oct;62(10):989-93
pubmed: 4899510
Lancet. 1976 Apr 3;1(7962):707-9
pubmed: 56530
J Virol. 1995 Oct;69(10):6158-69
pubmed: 7666518
Eur J Immunogenet. 1996 Feb;23(1):1-6
pubmed: 8834917
Clin Exp Rheumatol. 1998 Jan-Feb;16(1):107-8
pubmed: 9543579
Ann Dermatol Venereol. 1998 Jul;125(6-7):399-403
pubmed: 9747294